Clinical trial
Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free…
NCT00243386 · Baxalta now part of Shire, Industry · Completed
Key facts
| NCT number | NCT00243386 |
|---|---|
| Title | Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A |
| Official title | Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (ADVATE rAHF-PFM): A Phase 4 Study Comparing Two Prophylactic Regimens in Subjects With Severe or Moderately Severe Hemophilia A |
| Lead sponsor | Baxalta now part of Shire, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hemophilia A |
| Intervention type | Drug |
| Interventions | Antihemophilic factor, recombinant, manufactured protein-free |
| Enrollment | 82 |
| Start date | Jan 4, 2006 |
| Primary completion | Jun 16, 2010 |
| Completion | Jun 16, 2010 |
| First posted | Oct 24, 2005 |
| Last update posted | May 19, 2021 |
| Countries | Austria, Czechia, Greece, Hungary, Italy, Poland, Russia, Slovenia, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: